Clear Search sequence regions


  • biogenesis (1)
  • humans (1)
  • kras protein, human (1)
  • layer (1)
  • mirna (9)
  • mirna (2)
  • p21 ras (2)
  • protein human (1)
  • rat (6)
  • sarcoma (6)
  • Sizes of these terms reflect their relevance to your search.

    Extensive studies have focused on the misregulation of individual miRNAs in cancer. More recently, mutations in the miRNA biogenesis and processing machinery have been implicated in several malignancies. Such mutations can lead to global miRNA misregulation, which may promote many of the well-known hallmarks of cancer. Interestingly, recent evidence also suggests that oncogenic Kristen rat sarcoma viral oncogene homolog (KRAS) mutations act in part by modulating the activity of members of the miRNA regulatory pathway. Here, we highlight the vital role mutations in the miRNA core machinery play in promoting malignant transformation. Furthermore, we discuss how mutant KRAS can simultaneously impact multiple steps of miRNA processing and function to promote tumorigenesis. Although the ability of KRAS to hijack the miRNA regulatory pathway adds a layer of complexity to its oncogenic nature, it also provides a potential therapeutic avenue that has yet to be exploited in the clinic. Moreover, concurrent targeting of mutant KRAS and members of the miRNA core machinery represents a potential strategy for treating cancer. ©2023 The Authors; Published by the American Association for Cancer Research.

    Citation

    Angelina S Bortoletto, Ronald J Parchem. KRAS Hijacks the miRNA Regulatory Pathway in Cancer. Cancer research. 2023 May 15;83(10):1563-1572

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36946612

    View Full Text